Brendan Teehan - Net Worth and Insider Trading

Brendan Teehan Net Worth

The estimated net worth of Brendan Teehan is at least $648,281 dollars as of 2024-04-28. Brendan Teehan is the EVP, COO, HEAD OF COMMERCIAL of ACADIA Pharmaceuticals Inc and owns about 38,796 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $648,281. Details can be seen in Brendan Teehan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Brendan Teehan has not made any transactions after 2024-04-08 and currently still holds the listed stock(s).

Transaction Summary of Brendan Teehan

To

Brendan Teehan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brendan Teehan owns 1 companies in total, including ACADIA Pharmaceuticals Inc (ACAD) .

Click here to see the complete history of Brendan Teehan’s form 4 insider trades.

Insider Ownership Summary of Brendan Teehan

Ticker Comapny Transaction Date Type of Owner
ACAD ACADIA Pharmaceuticals Inc 2024-04-08 EVP & COO & Head of Commercial

Brendan Teehan Latest Holdings Summary

Brendan Teehan currently owns a total of 1 stock. Brendan Teehan owns 38,796 shares of ACADIA Pharmaceuticals Inc (ACAD) as of April 8, 2024, with a value of $648,281.

Latest Holdings of Brendan Teehan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACAD ACADIA Pharmaceuticals Inc 2024-04-08 38,796 16.71 648,281

Holding Weightings of Brendan Teehan


Brendan Teehan Form 4 Trading Tracker

According to the SEC Form 4 filings, Brendan Teehan has made a total of 13 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 2,568 shares on April 8, 2024, which brought Brendan Teehan around $45,890.

Insider Trading History of Brendan Teehan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Brendan Teehan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Brendan Teehan Ownership Network

Ownership Network List of Brendan Teehan

No Data

Ownership Network Relation of Brendan Teehan


Brendan Teehan Owned Company Details

What does ACADIA Pharmaceuticals Inc do?

Who are the key executives at ACADIA Pharmaceuticals Inc?

Brendan Teehan is the EVP & COO & Head of Commercial of ACADIA Pharmaceuticals Inc. Other key executives at ACADIA Pharmaceuticals Inc include Chief Financial Officer Mark C. Schneyer , Principal Accounting Officer James Kihara , and director & PRESIDENT AND CEO Stephen Davis .

ACADIA Pharmaceuticals Inc (ACAD) Insider Trades Summary

Over the past 18 months, Brendan Teehan made 10 insider transaction in ACADIA Pharmaceuticals Inc (ACAD) with a net sale of 32,184. Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 300,905 shares made by Stephen Davis , a net sale of 17,770 shares made by James Kihara , and a net sale of 42,807 shares made by Mark C. Schneyer .

In summary, during the past 3 months, insiders sold 69,383 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 69,383 shares. During the past 18 months, 433,237 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 896,522 shares were bought by its insiders, resulting in a net purchase of 463,285 shares.

ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ACADIA Pharmaceuticals Inc Insider Transactions

No Available Data

Brendan Teehan Mailing Address

Above is the net worth, insider trading, and ownership report for Brendan Teehan. You might contact Brendan Teehan via mailing address: C/o Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego Ca 92130.

Discussions on Brendan Teehan

No discussions yet.